Tom Nesi, former director of public affairs at Bristol-Myers Squibb, gives us the inside scoop from the pharmaceutical industry:
I would say the larger the marketing campaign, the more you should use caution. I would also say if there are good drugs in a category””in a type of illness that you suffer from””that have been out there for a while, there’s no reason not to use those first.
Here’s the whole interview. (via Daniel Carlat)
Related posts:
- "One of the more devious drug marketing campaigns in recent memory"
- Beware using the web for H1N1 pandemic flu drugs
- GlaxoSmithKline threatens Massachusetts
- Medical ghost-writing influences doctors to prescribe more drugs
- MGH psychiatrists in trouble
- Is there an ethical way to make $750/hour?
- Pristiq
KevinMD.com on Facebook
{ 1 comment }
I refuse to see drug reps and the few occasions that I do, just reiterates the reasons that I avoid reps like the plague. They are not here to educate, they are here to sell.
Instead I rely on non-biased sourse of information such as prescriber’s letter, up to date, and american medical seminars for my information. Unfortunately, my peers think that I’m insane for this practice… like I’m against “medical education” and staying current. I know generics aren’t as sexy as the newest brand name drugs (my favorite is progenitorivox) but I really feel my patients win out in the end.
Comments on this entry are closed.